CMS Issues Decision Memo for PET for Initial Treatment Strategy in Solid Tumors and Myeloma (CAG-00181R3)

August 5, 2010

CMS Issues Decision Memo for PET for Initial Treatment Strategy in Solid Tumors and Myeloma (CAG-00181R3)

The Centers for Medicare and Medicaid Services (CMS) has issued a decision memo for PET for initial treatment strategy in solid tumors and myeloma. The memo states that:

  1. the National Coverage Determinations (NCD) manual will be changed to remove the current absolute restriction of coverage to ‘only one’ FDG PET scan to determine the location and/or extent of the tumor for the therapeutic purposes related to the initial treatment strategy as described above; 
  2. CMS will continue to nationally cover one FDG PET scan to determine the location and/or extent of the tumor for the therapeutic purposes related to the initial treatment strategy as described above; and 
  3. local Medicare administrative contractors will have discretion to cover (or not cover) within their jurisdictions any additional FDG PET scan for the therapeutic purposes related to the initial treatment strategy as described above.